Member Info for bewise

Buddy, 554 has a great value adding future as it continues to prove itself. The IC headline is " Slow and steady at Verona Pharma" is a good summary. The company is pushing strongly ahead in the testing of 554 to take it to market as quickly as possible. I continue to be a believer as i look at the huge market$$$ for copd/asthma not to mention CF. Those with a negative attitude i disregard as i believe in the science and we have not had any bad results to date, in fact quite the opposite....As we are now on Nasdaq and as 554 continues to prove itself i have no doubt in my mind that a major could take a serious interest in us.

If somebody is prepared to invest such large sums then i would imagine they see 554 as a worthwhile investment. Its possible this could be the start again of an upward trend....lets see what happens

I would imagine the half mill sell is actually a buy along with the other large trade :)

They are really motoring ahead with the development of 554; plenty of results ahead for Q4 and 2018...

Buddy, go to the download centre on their websiite and you will see the June 17 presentation :) though the presentation this coming Tuesday 8th August will give us the latest update...

Jefferies Healthcare Conference Presentation 8 June 2017: Check this out on the vrp website, gives a good summary of where we are and whats coming up in H2 2017 and 2018.

LONDON, Aug. 01, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces today that Jan-Anders Karlsson, PhD, CEO of Verona Pharma, is scheduled to present at the 2017 Wedbush PacGrow Healthcare Conference. An audio webcast of the presentation will be available on the Investors section of the company website, www.veronapharma.com. A replay of the webcast will be made available for 90 days following the presentation. Event: Wedbush PacGrow Healthcare Conference Date: August 15, 2017 Time: 3:05 PM EDT Location: New York, NY About Verona Pharma plc

LONDON, Aug. 02, 2017 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (NASDAQ:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for respiratory diseases, announces today that it will report its interim results for the six months ended June 30, 2017 on Tuesday, August 8, 2017. Verona Pharma will host an investment community conference call at 8:00 a.m. Eastern Daylight Time (1:00 pm British Summer Time) on August 8, 2017 to discuss the interim financial results and provide a clinical development update. Analysts and investors may participate in the conference call by utilizing the conference ID: 4729485 and dialing the following numbers: -- (877)280-2296 or (646)254-3367 for callers in the United States -- 0800 279 4841 or 44(0)20 3427 1905 for callers in the United Kingdom -- 0800 589 2674 or 49(0)69 2222 10624 for calls in Germany Those interested in listening to the conference call live via the internet may do so by visiting the "Investors" page of Verona Pharma's website at www.veronapharma.com and clicking on the webcast link. A webcast replay of the conference call [audio] will be available on the "Investors" page of Verona Pharma's website at www.veronapharma.com.

The sp imo is bouncing about the bottom, results in Q4 and big results in 2018, so on positive news the sp can imo only go one way, so a canny investor who decides to take a punt could do very well in my speculative opinion....

Big year for us in 2018....

To sell a share on no news seems foolish to me imo and even more foolish if one listens to the BB's..now if there was a RNS detailing dreadful results then that would be a different matter. Sentiment can turn around very quickly here from the very bad (currently) to the very good.... my postion is to hold and add as we currently scrape along the bottom ranges....:)

Man the lifeboats, we are doomed lol.... imo I think we the sp is rolling about the bottom at the mo while we await news into the 4th quarter and 2018...i am still content with my investment here :)

http://investors.veronapharma.com/static-files/794b4b7f-0ce7-4203-81c0-c93ec4c2860c A good reminder of where we are going and it looks good :)

Our high profile II's dont think the same, if they did they would not invest in this if it was a road to no town and that would be the same for the cf foundation. Rpl554 has proved its self up to this point and exceptionally so....:)

I wont be selling and taking a loss based on yesterday trading and nothing much else from what i can see rather i will be adding at this level. I await results in 2018.

A curious day without rhyme nor reason it seems to me.....

Interesting to see if any big buys reported later..

Strange sp action on no news?!?

Good stuff, a lot of test result news to come end of 17 into 18, could next year be the year! Lets hope so!

A better finish on Nasdaq today :)